Clinical efficacy and safety of ultrasound-guided injection with low-molecular-weight peptides from hydrolyzed collagen in patients with first carpometacarpal joint osteoarthritis - Top-Institutions - MDSpire

Efficacy and Safety of Ultrasound-Guided Intra-Articular Injection of Low-Molecular-Weight Peptides from Hydrolyzed Collagen in Patients with Osteoarthritis of the First Carpometacarpal Joint

  • By

  • Marin Petric

  • Marco Di Carlo

  • Luca Latini

  • Riccardo Mashadi Mirza

  • Francesco Porta

  • Florentin Ananu Vreju

  • Emilio Filippucci

  • July 20, 2026

Share

Top Institutions in Orthopedic Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Rheumatology

  • #3

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Rheumatology

  • #4

    Zhujiang Hospital, Southern Medical University
    Zhujiang Hospital, Southern Medical University

    Guangzhou, China

    Key Differentiators

    • Rheumatology

  • #5

    Thammasat University Hospital
    Thammasat University Hospital

    Pathum Thani, Thailand

    Key Differentiators

    • Rheumatology

Original Source(s)

Clinical efficacy and safety of ultrasound-guided injection with low-molecular-weight peptides from hydrolyzed collagen in patients with first carpometacarpal joint osteoarthritis

  • by Marin Petric, Marco Di Carlo, Luca Latini, Riccardo Mashadi Mirza, Francesco Porta, Florentin Ananu Vreju, Emilio Filippucci

  • July 20, 2026

Related Content

Post-infection physeal bar resection of the proximal tibia: a case report and narrative review of the literature

Gout and allopurinol adherence in newly diagnosed patients and the risk of fractures: a nationwide cohort study

Tenderness Tracks Ultrasound Findings

Joint tenderness showed broader associations with concurrent ultrasound abnormalities than patient-reported pain among anti-cyclic citrullinated peptide–positive patients without clinical arthritis.